Nicholas Adams - Bioquell Plc Group Chief Executive and Executive Director

Director

Mr. Nicholas M. T. Adams is Chief Executive, Executive Director of Bioquell PLC. He Joined the Board in May 1997 and was appointed Chief Executive in May 1998. Previously he was a Director of Corporationrationrate Finance at Barings, an investment bank, having spent nine years in Barings Corporationrationrate Finance Department both in the UK and continental Europe. He read chemistry at Durham University. since 1998.
Tenure 26 years
Phone44 1264 835 835
Webhttp://www.bioquellplc.com

Bioquell Plc Management Efficiency

The company has return on total asset (ROA) of 6.36 % which means that it generated a profit of $6.36 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on equity (ROE) of 12.0 %, meaning that it generated $12.0 on every $100 dollars invested by stockholders. Bioquell Plc's management efficiency ratios could be used to measure how well Bioquell Plc manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

DIRECTOR Age

Robert ManzoVisteon Corp
61
Christine YanModine Manufacturing
55
Heidi SepanikVisteon Corp
N/A
Keith WandellConstellation Brands Class
69
Joanne MaguireVisteon Corp
65
Henry BeinsteinVector Group
77
Till WilmschenWallbox NV
N/A
Duncan CocroftVisteon Corp
71
Kristopher DoyleVisteon Corp
N/A
Eric AshlemanModine Manufacturing
54
Nomi BergmanVisteon Corp
N/A
Kam YuenVisteon Corp
69
Naomi BergmanVisteon Corp
55
David BillsModine Manufacturing
59
Jerry FowdenConstellation Brands Class
63
Frederic CumenalConstellation Brands Class
55
Judy SchmelingConstellation Brands Class
60
Jeffrey JonesVisteon Corp
66
Charles CooleyModine Manufacturing
64
Daniel McCarthyConstellation Brands Class
56
Suresh GarimellaModine Manufacturing
56
Bioquell plc designs, manufactures, and supplies bio-decontamination and containment equipment, and related products and services in the United Kingdom and internationally. The company was incorporated in 1925 and is headquartered in Andover, the United Kingdom. Bioquell plc operates under Medical Devices classification in USA and is traded on OTC Market. It employs 220 people. Bioquell Plc [BIQLF] is traded as part of a regulated electronic trading bulletin board offered by the NASD.

Management Performance

Bioquell Plc Leadership Team

Elected by the shareholders, the Bioquell Plc's board of directors comprises two types of representatives: Bioquell Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bioquell. The board's role is to monitor Bioquell Plc's management team and ensure that shareholders' interests are well served. Bioquell Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bioquell Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ian Johnson, Non-Executive Chairman of the Board
Nigel Keen, Independent Non-Executive Chairman of the Board
Nicholas Adams, Group Chief Executive and Executive Director
Christopher Mills, Non-Executive Director
Anthony Bourne, Independent Non-Executive Director
Georgina Pope, Company Secretary
Michael Roller, Group Finance Director, Director
Ian Carruthers, Independent Non-Executive Director
Simon Constantine, Independent Non-Executive Director

Bioquell Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc bb equity is not an easy task. Is Bioquell Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Bioquell Plc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioquell Plc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioquell Plc will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Helmerich could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Helmerich when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Helmerich - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Helmerich and Payne to buy it.
The correlation of Helmerich is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Helmerich moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Helmerich and Payne moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Helmerich can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Consideration for investing in Bioquell OTC BB Equity

If you are still planning to invest in Bioquell Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bioquell Plc's history and understand the potential risks before investing.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bonds Directory
Find actively traded corporate debentures issued by US companies
Global Correlations
Find global opportunities by holding instruments from different markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon